JP2015526452A5 - - Google Patents

Download PDF

Info

Publication number
JP2015526452A5
JP2015526452A5 JP2015527878A JP2015527878A JP2015526452A5 JP 2015526452 A5 JP2015526452 A5 JP 2015526452A5 JP 2015527878 A JP2015527878 A JP 2015527878A JP 2015527878 A JP2015527878 A JP 2015527878A JP 2015526452 A5 JP2015526452 A5 JP 2015526452A5
Authority
JP
Japan
Prior art keywords
tetrazol
tetrahydro
cyclohepta
pyridine
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015527878A
Other languages
English (en)
Japanese (ja)
Other versions
JP6258937B2 (ja
JP2015526452A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2013/067220 external-priority patent/WO2014029723A1/en
Publication of JP2015526452A publication Critical patent/JP2015526452A/ja
Publication of JP2015526452A5 publication Critical patent/JP2015526452A5/ja
Application granted granted Critical
Publication of JP6258937B2 publication Critical patent/JP6258937B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015527878A 2012-08-24 2013-08-19 新規二環式ピリジン誘導体 Expired - Fee Related JP6258937B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12181739.9 2012-08-24
EP12181739 2012-08-24
PCT/EP2013/067220 WO2014029723A1 (en) 2012-08-24 2013-08-19 New bicyclicpyridine derivatives

Publications (3)

Publication Number Publication Date
JP2015526452A JP2015526452A (ja) 2015-09-10
JP2015526452A5 true JP2015526452A5 (OSRAM) 2016-10-06
JP6258937B2 JP6258937B2 (ja) 2018-01-10

Family

ID=46851316

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015527878A Expired - Fee Related JP6258937B2 (ja) 2012-08-24 2013-08-19 新規二環式ピリジン誘導体

Country Status (13)

Country Link
US (1) US9562052B2 (OSRAM)
EP (1) EP2888245B1 (OSRAM)
JP (1) JP6258937B2 (OSRAM)
KR (1) KR20150046056A (OSRAM)
CN (1) CN104583197B (OSRAM)
AR (1) AR092223A1 (OSRAM)
BR (1) BR112015002950A2 (OSRAM)
CA (1) CA2873295A1 (OSRAM)
ES (1) ES2596243T3 (OSRAM)
MX (1) MX2015001099A (OSRAM)
RU (1) RU2648247C2 (OSRAM)
TW (1) TWI614237B (OSRAM)
WO (1) WO2014029723A1 (OSRAM)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014517079A (ja) 2011-06-22 2014-07-17 バーテックス ファーマシューティカルズ インコーポレイテッド Atrキナーゼ阻害剤として有用な化合物
TR201807740T4 (tr) 2012-12-07 2018-06-21 Vertex Pharma ATR kinaz inhibitörü olarak 2-amino-6-fluoro-n-(5-fluoro-4-(4-(4-(oksetan-3-il)piperazin-1-karbonil)piperidin-1-il)piridin-3-il)pirazolo[1,5alfa]pirimidin-3-karboksamid.
EP2970288A1 (en) 2013-03-15 2016-01-20 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of atr kinase
EP2970286A1 (en) 2013-03-15 2016-01-20 Vertex Pharmaceuticals Inc. Fused pyrazolopyrimidine derivatives useful as inhibitors of atr kinase
WO2014143241A1 (en) 2013-03-15 2014-09-18 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of atr kinase
WO2015085132A1 (en) 2013-12-06 2015-06-11 Vertex Pharmaceuticals Incorporated 2-amino-6-fluoro-n-[5-fluoro-pyridin-3-yl]pyrazolo[1,5-a]pyrimidin-3-carboxamide compound useful as atr kinase inhibitor, its preparation, different solid forms and radiolabelled derivatives thereof
SI3152212T1 (sl) 2014-06-05 2020-06-30 Vertex Pharmaceuticals Inc. Radioaktivno označeni derivati 2-amino-6-fluoro-N-(5-fluoro-piridin-3-IL)-pirazolo (1,5-A)pirimidin-3- karboksamidne spojine, koristni kot inhibitor kinaze ATR, priprava navedene spojine in njene različne trdne oblike
LT3157566T (lt) 2014-06-17 2019-08-12 Vertex Pharmaceuticals Incorporated Vėžio gydymo būdas, panaudojant chk1 ir atr inhibitorių derinį
AU2016331955B2 (en) 2015-09-30 2022-07-21 Vertex Pharmaceuticals Incorporated Method for treating cancer using a combination of DNA damaging agents and ATR inhibitors
CN107556309B (zh) * 2017-09-11 2020-12-01 浙江永宁药业股份有限公司 多取代四氢萘啶类化合物的药物用途及其制备方法
CN107540672A (zh) * 2017-10-10 2018-01-05 牡丹江医学院 一种治疗肝硬化的药物及其合成方法
US12084419B2 (en) 2020-06-27 2024-09-10 Crescenta Biosciences Cell metabolism modulating compounds and uses thereof
US20240132431A1 (en) * 2021-01-06 2024-04-25 Chugai Seiyaku Kabushiki Kaisha Method for alkylating acidic functional group
CA3232232A1 (en) 2021-09-24 2023-03-30 Xenon Pharmaceuticals Inc. Pyridine derivatives and their use as sodium channel activators
US12138243B2 (en) 2021-12-31 2024-11-12 Crescenta Biosciences Antiviral use of FABP4 modulating compounds
CN114907372B (zh) * 2022-04-26 2023-07-04 黑龙江中医药大学 一种用于治疗多囊卵巢综合征的药物及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW232013B (OSRAM) * 1992-04-24 1994-10-11 Takeda Pharm Industry Co Ltd
NO940245D0 (no) * 1993-01-28 1994-01-24 Takeda Chemical Industries Ltd Quinolin eller quinazolinderivater, deres fremstilling og anvendelse
DE69422450T2 (de) * 1993-06-29 2000-06-08 Takeda Chemical Industries, Ltd. Chinoline oder Chinazolin-Derivate und deren Verwendung zur Herstellung eines Medikaments für die Behandlung von Osteoporose
AR008789A1 (es) * 1996-07-31 2000-02-23 Bayer Corp Piridinas y bifenilos substituidos
TW477787B (en) * 1996-08-27 2002-03-01 Pfizer Pyrido six-membered nitrogen-containing cyclic ring derivatives having corticotropin releasing factor antagonist activity and pharmaceutical composition containing same
DE19741399A1 (de) * 1997-09-19 1999-03-25 Bayer Ag Tetrahydrochinoline
JP4473698B2 (ja) * 2003-10-31 2010-06-02 武田薬品工業株式会社 ピリジン化合物
US7521557B2 (en) * 2005-05-20 2009-04-21 Bristol-Myers Squibb Company Pyrrolopyridine-based inhibitors of dipeptidyl peptidase IV and methods
JO3077B1 (ar) * 2005-07-28 2017-03-15 Janssen Pharmaceutica Nv مشتقات كوينولين مضادة للبكتيريا
US7994321B2 (en) * 2006-08-08 2011-08-09 Hoffmann-La Roche Inc. Substituted thieno[3,2-C]pyridine-7-carboxylic acid derivatives
JP2010510317A (ja) * 2006-11-20 2010-04-02 ブリストル−マイヤーズ スクイブ カンパニー ジペプチジルペプチダーゼivの阻害剤としての7,8−ジヒドロ−1,6−ナフチリジン−5(6h)−オンおよび関連二環式化合物、および方法
CN101245062A (zh) * 2007-02-16 2008-08-20 中国科学院上海药物研究所 四氢喹啉类化合物、其制备方法及药物组合物
JP2012508692A (ja) * 2008-11-12 2012-04-12 シェーリング コーポレイション 脂肪酸結合タンパク質(fabp)の阻害薬
US8889683B2 (en) * 2010-09-27 2014-11-18 Merck Sharp & Dohme Corp. Substituted quinoxalines as inhibitors of fatty acid binding protein
CA2849945A1 (en) * 2011-11-04 2013-05-10 F.Hoffmann-La Roche Ag New aryl-quinoline derivatives

Similar Documents

Publication Publication Date Title
JP2015526452A5 (OSRAM)
RU2015107979A (ru) Новые бициклические производные пиридина
JP2010524974A5 (OSRAM)
AU2013329552B2 (en) 5-phenoxy-3H-pyrimidin-4-one derivatives and their use as HIV reverse transcriptase inhibitors
JP2010524970A5 (OSRAM)
JP2016519096A5 (OSRAM)
JP2016500073A5 (OSRAM)
JP2007504148A5 (OSRAM)
RU2015100942A (ru) Производное пиперидинилпиразолпиридина
JP2015500332A5 (OSRAM)
JP2013527173A5 (OSRAM)
JP2013508404A5 (OSRAM)
JP2013528591A5 (OSRAM)
SI3177619T1 (en) 2- (morpholin-4-yl) -1,7-naphthyridines
JP2013525498A5 (OSRAM)
EP2146716A1 (en) Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
HRP20130054T1 (hr) Spojevi pirazina kao inhibitori fosfodiesteraze 10
JP2012508776A5 (OSRAM)
JP2017502049A5 (OSRAM)
JP2016514718A5 (OSRAM)
CA2798622A1 (en) Indoles
JP2017500364A5 (OSRAM)
IL263511A (en) 1h-pyrazolo[4,3-b]pyridines as pde1 inhibitors
JP2014528446A5 (OSRAM)
JP2016507551A5 (OSRAM)